(1S,2S,6R,14R,15S,16R)-5-(cyclopropylmethyl)-16-(2-hydroxy-3,3-dimethylbutan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol

• 分子结构分类: 有机化合物 - 苯类化合物 - 菲及其衍生物
• 英文名称: (1S,2S,6R,14R,15S,16R)-5-(cyclopropylmethyl)-16-(2-hydroxy-3,3-dimethylbutan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
• 化学式: C₂₉H₄₁NO₄
• 分子量: 467.6
• InChiKey: RMRJXGBAOAMLHD-IJIMNVSZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  34
• 可旋转键数：
  5
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.79
• 拓扑面积：
  62.2
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• PROCESS FOR THE PREPARATION OF OPIOID COMPOUNDS
  申请人：NORAMCO, INC.

  公开号：US20150315205A1

  公开（公告）日：2015-11-05

  The present invention is directed to a process for the preparation of opioid compounds such as buprenorphine, naltrexone, naloxone, nalbuphone, nalbuphine, and the like.

  本发明涉及一种制备类鸦片类化合物（如布洛芬、纳曲酮、纳洛酮、纳布酮、纳布啡等）的方法。
• 4-FLUORO-4-ARYLPIPERDIN-1-YL DERIVATIVES AS MU OPIOID FUNCTION MODERATORS
  申请人：Fairfax David J.

  公开号：US20130045165A1

  公开（公告）日：2013-02-21

  4-Fluoro-4-phenylpiperidin- 1 -yl μ antagonists of general structure as well as pharmaceutical compositions comprising compounds of formula I, are disclosed. These compounds and compositions are useful as treatments of conditions or diseases associated with binding opioid receptors including pain, obesity, hyperalgesia, inflammation, osteoarthritis, drug addiction, and cancer. These compounds and compositions are also useful as treatments for tardive dyskinesia.

  本发明涉及一种通用结构的4-氟-4-苯基哌啶-1-基μ拮抗剂，以及包含式I化合物的制药组合物。这些化合物和组合物可用于治疗与结合阿片受体有关的疾病或症状，包括疼痛、肥胖症、高痛敏性、炎症、骨关节炎、药物成瘾和癌症。这些化合物和组合物还可用于治疗迟发性运动障碍。
• QUATERNARY OPIOID CARBOXAMIDES
  申请人：Rensselaer Polytechnic Institute

  公开号：US20140107143A1

  公开（公告）日：2014-04-17

  Compounds of formulas: are disclosed. The compounds are useful for ameliorating the side effects of therapeutic opiates.

  公式为：的化合物已经被披露。这些化合物对于改善治疗性鸦片副作用是有用的。
• MORPHINANE DERIVATIVES CONTAINING A CARBOXAMIDE GROUP AS OPIOID RECEPTOR LIGANDS
  申请人：Rensselaer Polytechnic Institute

  公开号：EP2550253B1

  公开（公告）日：2016-04-27
• LARGE SUBSTITUENT, NON-PHENOLIC OPIOIDS AND METHODS OF USE THEREOF
  申请人：Wentland Mark P.

  公开号：US20090247562A1

  公开（公告）日：2009-10-01

  8-Substituted-2,6-methano-3-benzazocines of general structure are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications.